Soham Rej, MD, MSc, FRCPC

Department of Psychiatry, Jewish General Hospital, Montreal, Quebec, Canada; Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada; School of Nursing and Midwifery, Queen’s University Belfast, Belfast, Northern Ireland, United Kingdom

  • 6Articles
  • 31.7KReads
  • 2011–2025Active
  • 50Collaborators
  • 217Citations

About

Soham Rej, MD, MSc, FRCPC, is affiliated with the Department of Psychiatry and Lady Davis Institute at Jewish General Hospital in Montreal, as well as the School of Nursing and Midwifery at Queen’s University Belfast. Rej has published extensively on topics including major depressive disorder, bipolar disorder, and the renal effects of lithium treatment in older adults. Research contributions include studies on personalized depression treatment using artificial intelligence, lithium monitoring practices, and the renal risks associated with mood stabilizers.

Publications

JCP
Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management
Original Research

Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management

August 27, 2025

This study provides preliminary evidence that longitudinal use of an AI-enabled clinical decision support system can improve outcomes in MDD.
, , , et al
JCP
Original Research

Lithium and Renal Function in Older Adults

August 18, 2020

Lithium is an important mood disorder treatment, but the renal risks in older adults are unclear. This population-based cohort study looked at risk of renal decline with lithium vs...
, , , et al
JCP
Meta-Analysis

Exercise for Late-Life Depression

January 21, 2020

Evidence for an effect of exercise on depression in older adults is scant and heterogeneous. This meta-analysis included trials with a specific exercise dose and assessed sources of heterogeneity—read...
, , , et al
JCP
Article

Lithium Monitoring in Older Adults

November 20, 2018

Lithium treatment, while effective for mood disorders, necessitates frequent drug level and renal monitoring in older patients to prevent serious adverse events. Read this article to see if older...
, , , et al
JCP
Original Research

Lithium Use and Chronic Kidney Disease in Older Adults

August 1, 2017

Could mood-stabilizing medications be increasing patients' risk of developing kidney disease? This large, nested case-control study looks at the degree of risk associated with lithium and valproate treatment in...
, , , et al
PCC
Letter to the Editor

Diabetes Insipidus Secondary to Combination Atypical Antipsychotic and Lithium Use in a Bipolar Disorder Patient: A Case Report

July 21, 2011

, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe